OctaneRender adds a neural viewport mode, AI Light 2.0, and USD export in the first 2027.1 public alpha for Windows.

I make short, to-the-point online math tutorials. I struggled with math growing up and have been able to use those ...

A recent LLVM compiler submission provides another technical indicator of how AMD is shaping its next-generation RDNA 5 graphics architecture, also associated with the broader UDNA transition.

In this video playlist, I show you how to solve different math problems for Algebra, Geometry, Algebra 2, and Pre-Calculus.

Vertex Pharmaceuticals is the leader in cystic fibrosis treatment. The company has also expanded into other areas in recent years, winning approval for two new drugs. Vertex is the global leader in ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Vertex Pharmaceuticals ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Thursday afternoon. Here’s what you need to know. Vertex Pharmaceuticals met analysts’ revenue expectations last ...

Vertex has delivered earnings growth over the past decade thanks to its leadership in cystic fibrosis treatment. In recent years, the company has launched products in other treatment areas too. On top ...

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Journavx and Casgevy sales remain niche, raising doubts about their ability to drive ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

In unresectable stage III non–small cell lung cancer (NSCLC) with bulky primary tumors and extensive nodal irradiation volumes, dose escalation during concurrent chemoradiotherapy (cCRT) is often ...